Autologous cardiac progenitor cells (CPCs) isolated as cardiospheres (CSps) represent a promising candidate for cardiac regenerative therapy. A better understanding of the origin and mechanisms underlying human CSps formation and maturation is undoubtedly required to enhance their cardiomyogenic potential. Epithelial-to-mesenchymal transition (EMT) is a key morphogenetic process that is implicated in the acquisition of stem cell-like properties in different adult tissues, and it is activated in the epicardium after ischemic injury to the heart. We investigated whether EMT is involved in the formation and differentiation of human CSps, revealing that an up-regulation of the expression of EMT-related genes accompanies CSps formation that is relative to primary explant-derived cells and CSp-derived cells grown in a monolayer. EMT and CSps formation is enhanced in the presence of transforming growth factor β1 (TGFβ1) and drastically blocked by the type I TGFβ-receptor inhibitor SB431452, indicating that TGFβ-dependent EMT is essential for the formation of these niche-like 3D-multicellular clusters. Since TGFβ is activated in the myocardium in response to injury, our data suggest that CSps formation mimics an adaptive mechanism that could potentially be enhanced to increase in vivo or ex vivo regenerative potential of adult CPCs.
Get full access to this article
View all access options for this article.
References
1.
DobaczewskiM, Gonzalez-QuesadaC, FrangogiannisNG. 2010. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol, 48:504–511.
2.
PfefferMA, BraunwaldE. 1990. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation, 81:1161–1172.
3.
GaetaniR, BarileL, ForteE, ChimentiI, IontaV, Di ConsiglioA, MiraldiF, FratiG, MessinaE, GiacomelloA. 2009. New perspectives to repair a broken heart. Cardiovasc Hematol Agents Med Chem, 7:91–107.
4.
ForteE, ChimentiI, BarileL, GaetaniR, AngeliniF, IontaV, MessinaE, GiacomelloA. 2011. Cardiac cell therapy: the next (re)generation. Stem Cell Rev, 7:1018–1030.
5.
MessinaE, De AngelisL, FratiG, MorroneS, ChimentiS, FiordalisoF, SalioM, BattagliaM, LatronicoMVet al. 2004. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res, 95:911–921.
DavisDR, Ruckdeschel SmithR, MarbanE. 2010. Human cardiospheres are a source of stem cells with cardiomyogenic potential. Stem Cells, 28:903–904.
8.
MakkarRR, SmithRR, ChengK, MalliarasK, ThomsonLE, BermanD, CzerLS, MarbanL, MendizabalAet al. 2012. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet, 379:895–904.
9.
LiTS, ChengK, MalliarasK, SmithRR, ZhangY, SunB, MatsushitaN, BlusztajnA, TerrovitisJet al. 2012. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol, 59:942–953.
10.
LiTS, ChengK, LeeST, MatsushitaS, DavisD, MalliarasK, ZhangY, MatsushitaNet al. 2010. Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells, 28:2088–2098.
11.
LeeST, WhiteAJ, MatsushitaS, MalliarasK, SteenbergenC, ZhangY, LiTS, TerrovitisJet al. 2011. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol, 57:455–465.
12.
ShenD, ChengK, MarbanE. 2012. Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. J Cell Mol Med[Epub ahead of print]DOI:10.1111/j.1582-4934.2011.01512.x
13.
ChimentiI, SmithRR, LiTS, GerstenblithG, MessinaE, GiacomelloA, MarbanE. 2010. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res, 106:971–980.
14.
BoudoulasKD, HatzopoulosAK. 2009. Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease. Dis Model Mech., 2:344–358.
15.
ZavadilJ, BottingerEP. 2005. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene, 24:5764–5774.
LapingNJ, GrygielkoE, MathurA, ButterS, BombergerJ, TweedC, MartinW, FornwaldJ, LehrRet al. 2002. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol, 62:58–64.
18.
KalluriR, WeinbergRA. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest, 119:1420–1428.
19.
ChuaKN, PoonKL, LimJ, SimWJ, HuangRY, ThieryJP. 2011. Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept. Adv Drug Deliv Rev, 63:558–567.
20.
ManiSA, GuoW, LiaoMJ, EatonEN, AyyananA, ZhouAY, BrooksM, ReinhardF, ZhangCCet al. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133:704–715.
21.
CajaL, BertranE, CampbellJ, FaustoN, FabregatI. 2011. The transforming growth factor-beta (TGF-beta) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells. J Cell Physiol, 226:1214–1223.
22.
ChimentiI, GaetaniR, BarileL, ForteE, IontaV, AngeliniF, FratiG, MessinaE, GiacomelloA. 2012. Isolation and expansion of adult cardiac stem/progenitor cells in the form of cardiospheres from human cardiac biopsies and murine hearts. Methods Mol Biol, 879:327–338.
23.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK, YamanakaS. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
IedaM, FuJD, Delgado-OlguinP, VedanthamV, HayashiY, BruneauBG, SrivastavaD. 2010. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell, 142:375–386.
26.
QianL, HuangY, SpencerCI, FoleyA, VedanthamV, LiuL, ConwaySJ, FuJD, SrivastavaD. 2012. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature, 485:593–598.
27.
GustafssonMV, ZhengX, PereiraT, GradinK, JinS, LundkvistJ, RuasJL, PoellingerL, LendahlU, BondessonM. 2005. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell, 9:617–628.
28.
JordanNV, JohnsonGL, AbellAN. 2011. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle, 10:2865–2873.
29.
KluppelM, WranaJL. 2005. Turning it up a Notch: cross-talk between TGF beta and Notch signaling. Bioessays, 27:115–118.
30.
NemirM, PedrazziniT. 2008. Functional role of Notch signaling in the developing and postnatal heart. J Mol Cell Cardiol, 45:495–504.
31.
SansoneP, StorciG, GiovanniniC, PandolfiS, PianettiS, TaffurelliM, SantiniD, CeccarelliC, ChiecoP, BonafeM. 2007. p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Stem Cells, 25:807–815.
32.
LiR, LiangJ, NiS, ZhouT, QingX, LiH, HeW, ChenJ, LiFet al. 2010. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell, 7:51–63.
33.
ZhangR, HanM, ZhengB, LiYJ, ShuYN, WenJK. 2010. Kruppel-like factor 4 interacts with p300 to activate mitofusin 2 gene expression induced by all-trans retinoic acid in VSMCs. Acta Pharmacol Sin, 31:1293–1302.
34.
ZeisbergM, ShahAA, KalluriR. 2005. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem, 280:8094–8100.
35.
Asazuma-NakamuraY, DaiP, HaradaY, JiangY, HamaokaK, TakamatsuT. 2009. Cx43 contributes to TGF-beta signaling to regulate differentiation of cardiac fibroblasts into myofibroblasts. Exp Cell Res, 315:1190–1199.
36.
SagaY, KitajimaS, Miyagawa-TomitaS. 2000. Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med, 10:345–352.
37.
WillemsE, LanierM, ForteE, LoF, CashmanJ, MercolaM. 2011. A chemical biology approach to myocardial regeneration. J Cardiovasc Transl Res, 4:340–350.
38.
LickertH, TakeuchiJK, Von BothI, WallsJR, McAuliffeF, AdamsonSL, HenkelmanRM, WranaJL, RossantJ, BruneauBG. 2004. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature, 432:107–112.
LimanaF, CapogrossiMC, GermaniA. 2011. The epicardium in cardiac repair: from the stem cell view. Pharmacol Ther, 129:82–96.
43.
WagnerKD, WagnerN, BondkeA, NafzB, FlemmingB, TheresH, ScholzH. 2002. The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction. FASEB J, 16:1117–1119.
KanemuraY, MoriH, KobayashiS, IslamO, KodamaE, YamamotoA, NakanishiY, AritaN, YamasakiMet al. 2002. Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity. J Neurosci Res, 69:869–879.
46.
InmanGJ, NicolasFJ, CallahanJF, HarlingJD, GasterLM, ReithAD, LapingNJ, HillCS. 2002. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol, 62:65–74.
47.
BaxNA, van OorschotAA, MaasS, BraunJ, van TuynJ, de VriesAA, GrootAC, GoumansMJ. 2011. In vitro epithelial-to-mesenchymal transformation in human adult epicardial cells is regulated by TGFbeta-signaling and WT1. Basic Res Cardiol, 106:829–847.
48.
WillisBC, BorokZ. 2007. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol, 293:L525–L534.
49.
HalderSK, BeauchampRD, DattaPK. 2005. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia, 7:509–521.
50.
AltomareC, BarileL, MarangoniS, RocchettiM, AlemanniM, MostacciuoloG, GiacomelloA, MessinaE, ZazaA. 2010. Caffeine-induced Ca(2+) signaling as an index of cardiac progenitor cells differentiation. Basic Res Cardiol, 105:737–749.
ZhouB, MaQ, RajagopalS, WuSM, DomianI, Rivera-FelicianoJ, JiangD, von GiseA, IkedaSet al. 2008. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature, 454:109–113.
53.
LimanaF, BertolamiC, MangoniA, Di CarloA, AvitabileD, MociniD, IannelliP, De MoriR, MarchettiCet al. 2010. Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. J Mol Cell Cardiol, 48:609–618.
54.
Martinez-EstradaOM, LetticeLA, EssafiA, GuadixJA, SlightJ, VelecelaV, HallE, ReichmannJ, DevenneyPSet al. 2010. Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat Genet, 42:89–93.
55.
LimanaF, ZacheoA, MociniD, MangoniA, BorsellinoG, DiamantiniA, De MoriR, BattistiniL, VignaEet al. 2007. Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res, 101:1255–1265.
56.
RussellJL, GoetschSC, GaianoNR, HillJA, OlsonEN, SchneiderJW. 2011. A dynamic notch injury response activates epicardium and contributes to fibrosis repair. Circ Res, 108:51–59.
57.
Di MeglioF, CastaldoC, NurzynskaD, RomanoV, MiragliaR, BanconeC, LangellaG, VosaC, MontagnaniS. 2010. Epithelial-mesenchymal transition of epicardial mesothelium is a source of cardiac CD117-positive stem cells in adult human heart. J Mol Cell Cardiol, 49:719–727.
58.
BlokzijlA, DahlqvistC, ReissmannE, FalkA, MolinerA, LendahlU, IbanezCF. 2003. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol, 163:723–728.
59.
ZavadilJ, CermakL, Soto-NievesN, BottingerEP. 2004. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J, 23:1155–1165.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
